Target: HSP70 Acetyl Lys77.
Conjugate: FITC.
Product Type: Polyclonal.
Immunogen: Synthetic peptide from the N-terminal of Human HSP70 Acetyl Lys77 (1-100 aa), conjugated to Keyhole Limpet Haemocyanin (KLH).
Swiss-Prot: P0DMV8/P0DMV9.
Purification: Peptide Affinity Purified.
Storage Buffer: PBS pH 7.4, 50% glycerol, 0.09% Sodium Azide.
Concentration: 0.5mg/mL.
Specificity: Binds to acetylated lysine 77 on HSP70. Detects 70 kDa band.
Cellular Localization: Cytoplasm, Nucleus.
Scientific Background: HSP70 genes encode abundant heat-inducible 70-kDa HSPs (HSP70s). In most eukaryotes HSP70 genes exist as part of a multigene family. They are found in most cellular compartments of eukaryotes including nuclei, mitochondria, chloroplasts, the endoplasmic reticulum and the cytosol, as well as in bacteria. The genes show a high degree of conservation, having at least 50% identity (2). The N-terminal two thirds of HSP70s are more conserved than the C-terminal third. HSP70 binds ATP with high affinity and possesses a weak ATPase activity which can be stimulated by binding to unfolded proteins and synthetic peptides (3). When HSC70 (constitutively expressed) present in mammalian cells was truncated, ATP binding activity was found to reside in an N-terminal fragment of 44 kDa which lacked peptide binding capacity. Polypeptide binding ability therefore resided within the C-terminal half (4). The structure of this ATP binding domain displays multiple features of nucleotide binding proteins (5).All HSP70s, regardless of location, bind proteins, particularly unfolded ones. The molecular chaperones of the HSP70 family recognize and bind to nascent polypeptide chains as well as partially folded intermediates of proteins preventing their aggregation and misfolding. The binding of ATP triggers a critical conformational change leading to the release of the bound substrate protein (6). The universal ability of HSP70s to undergo cycles of binding to and release from hydrophobic stretches of partially unfolded proteins determines their role in a great variety of vital intracellular functions such as protein synthesis, protein folding and oligomerization and protein transport. For more information visit our HSP70 Scientific Resource Guide at http://www.HSP70.com.
References: 1. Welch W.J. and Suhan J.P. (1986) J Cell Biol. 103: 2035-2050.2. Boorstein W. R., Ziegelhoffer T. & Craig E. A. (1993) J.Mol. Evol. 38(1): 1-17.3. Rothman J. (1989) Cell 59: 591-601.4. DeLuca-Flaherty et al. (1990) Cell 62: 875-887.5. Bork P., Sander C. & Valencia A. (1992) Proc. Nut1 Acad. Sci. USA 89: 7290-7294.6. Fink A.L. (1999) Physiol. Rev. 79: 425-449.7. Galan A., et al. (2000) J. Biol. Chem. 275: 11418-11424.8. Kondo T., et al. (2000) J. Biol. Chem. 275: 8872-8879.9. Misaki T., et al. (1994) Clin. Exp. Immun. 98: 234-239.10. Pockley A.G., et al. (1998) Immunol. Invest. 27: 367-377.11. Moon I.S., et al. (2001) Cereb Cortex 11(3): 238-248.12. Dressel et al. (2000) J. Immunol. 164: 2362-2371.13. Verma A.K., et al. (2007) Fish and Shellfish Immunology. 22(5): 547-555.14. Banduseela V.C., et al. (2009) Physiol Genomics. 39(3): 141-159.
Field of Use: Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
English
Deutsch
